Phospholipase D2 Antikörper (AA 834-933)
-
- Target Alle Phospholipase D2 (PLD2) Antikörper anzeigen
- Phospholipase D2 (PLD2)
-
Bindungsspezifität
- AA 834-933
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser Phospholipase D2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Mouse monoclonal antibody raised against a partial recombinant PLD2.
- Sequenz
- LRDPICDDFF QLWQDMAESN ANIYEQIFRC LPSNATRSLR TLREYVAVEP LATVSPPLAR SELTQVQGHL VHFPLKFLED ESLLPPLGSK EGMIPLEVWT
- Kreuzreaktivität
- Human, Ratte
- Produktmerkmale
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- PLD2 (AAH15033, 834 a.a. ~ 933 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Klon
- 1C5
- Isotyp
- IgG2a
- Top Product
- Discover our top product PLD2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- In 1x PBS, pH 7.4
- Handhabung
- Aliquot to avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines." in: Investigational new drugs, Vol. 29, Issue 1, pp. 87-97, (2011) (PubMed).
: "
-
Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines." in: Investigational new drugs, Vol. 29, Issue 1, pp. 87-97, (2011) (PubMed).
-
- Target
- Phospholipase D2 (PLD2)
- Andere Bezeichnung
- PLD2 (PLD2 Produkte)
- Synonyme
- Pldc antikoerper, PLD2 antikoerper, phospholipase D2 antikoerper, PLD2 antikoerper, Pld2 antikoerper, pld2 antikoerper, CpipJ_CPIJ013122 antikoerper, VDBG_00892 antikoerper
- Hintergrund
-
Full Gene Name: phospholipase D2
Synonyms: - Gen-ID
- 5338
- Pathways
- RTK Signalweg, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
-